Issued Patents All Time
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10463676 | Modified-release dosage forms of 5-HT2C agonists useful for weight management | Zezhi Jesse Shao, Anthony C. Blackburn, Andrew J. Grottick, Michael E. Morgan, Jaimie Karyn Rueter +3 more | 2019-11-05 |
| 10226471 | Modified-release dosage forms of 5-HT2C agonists useful for weight management | Zezhi Jesse Shao, Anthony C. Blackburn, Andrew J. Grottick, Michael E. Morgan, Jaimie Karyn Rueter +3 more | 2019-03-12 |
| 9522133 | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders | Robert M. Jones, Daniel J. Buzard, Sangdon Han, Sun Hee Kim, Juerg Lehmann +3 more | 2016-12-20 |
| 9365521 | Non-hygroscopic salts of 5-HT2C agonists | Anthony C. Blackburn, Yun Shan, Anna Shifrina | 2016-06-14 |
| 9248133 | Salts of lorcaserin with optically active acids | Anthony C. Blackburn, William L. Betts, III, Jaimie Karyn Rueter, Yun Shan, Anna Shifrina | 2016-02-02 |
| 9085581 | Processes for the preparation of S1P1 receptor modulators and crystalline forms thereof | Robert M. Jones, Daniel J. Buzard, Tawfik Gharbaoui, Benjamin R. Johnson, Michelle Kasem +1 more | 2015-07-21 |
| 8980891 | Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto | Edward A. Lally | 2015-03-17 |
| 8580841 | Substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders | Robert M. Jones, Daniel J. Buzard, Sangdon Han, Sun Hee Kim, Juerg Lehmann +3 more | 2013-11-12 |